As the treatment of malignant tumors enters the era of precision targeted therapy, mTOR inhibitors—owing to their ability to precisely block key signaling pathways that drive tumor cell growth—have become cornerstone agents across multiple cancer types. Qingweishi® Everolimus Tablets, the first domestically developed generic and currently the only accessible locally manufactured...